Literature DB >> 7534629

Breast cancer.

G Ursin1, L Bernstein, M C Pike.   

Abstract

There is a four to fivefold variation in breast cancer incidence rates across different countries. The lowest rates are observed in Asia, and the highest rates are observed in western Europe and North America. The incidence of breast cancer has increased in all countries since 1960. We studied in detail (whenever possible) the changes in incidence and mortality between 1955 and 1990 in four age groups (35-44, 45-54, 55-64 and 65-74) for 11 "representative" countries (USA, England and Wales, Norway, Hungary, Yugoslavia, Spain, Colombia, Singapore, Japan, India and China). The largest increase in incidence took place in Japan and Singapore. The incidence rate for women aged 35-44 in Japan doubled between 1960 and 1985 and by 1985 was roughly two thirds the USA rate. There has been essentially no change in mortality rates in the USA, England and Wales or Norway, whereas there has been a 50-60% increase in Japan, Singapore and Hungary. Most of the observed increase in incidence rates in the USA, England and Wales and Norway may be "artefactual", that is, due to changes in screening patterns. Screening may also have contributed to the rate increase in other countries, but outside western Europe and North America the major part of the increase is likely to be due to changes in known and suspected breast cancer risk factors.

Entities:  

Mesh:

Year:  1994        PMID: 7534629

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  17 in total

1.  Environmental Risk Factors in Breast Cancer. Preface.

Authors:  Mary Beth Martin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-03       Impact factor: 2.673

2.  Breast cancer: a neglected disease for the majority of affected women worldwide.

Authors:  Ophira M Ginsburg; Richard R Love
Journal:  Breast J       Date:  2011-03-16       Impact factor: 2.431

3.  Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats.

Authors:  Bhupendra Singh; Sarah M Mense; Nimee K Bhat; Sandeep Putty; William A Guthiel; Fabrizio Remotti; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-22       Impact factor: 4.219

4.  Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.

Authors:  Sarah M Mense; Jaimeet Chhabra; Hari K Bhat
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-29       Impact factor: 4.292

5.  4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Fatma Abdalla; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-09       Impact factor: 4.219

6.  Sleep duration, melatonin and breast cancer among Chinese women in Singapore.

Authors:  Anna H Wu; Renwei Wang; Woon-Puay Koh; Frank Z Stanczyk; Hin-Peng Lee; Mimi C Yu
Journal:  Carcinogenesis       Date:  2008-04-30       Impact factor: 4.944

Review 7.  Potential utility of natural products as regulators of breast cancer-associated aromatase promoters.

Authors:  Shabana I Khan; Jianping Zhao; Ikhlas A Khan; Larry A Walker; Asok K Dasmahapatra
Journal:  Reprod Biol Endocrinol       Date:  2011-06-21       Impact factor: 5.211

Review 8.  The melatonin hypothesis: electric power and breast cancer.

Authors:  R G Stevens; S Davis
Journal:  Environ Health Perspect       Date:  1996-03       Impact factor: 9.031

9.  Trends in cancer incidence and mortality in Scotland: description and possible explanations.

Authors:  A J Swerdlow; I dos Santos Silva; A Reid; Z Qiao; D H Brewster; J Arrundale
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

Review 10.  Environmental pollutants and breast cancer.

Authors:  Julia Green Brody; Ruthann A Rudel
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.